Industry
Medical - Diagnostics & Research
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Loading...
Open
0.22
Mkt cap
4.9M
Volume
1.1M
High
0.23
P/E Ratio
-0.20
52-wk high
2.51
Low
0.22
Div yield
N/A
52-wk low
0.18
Portfolio Pulse from Benzinga Newsdesk
October 21, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Insights
October 15, 2024 | 4:32 pm
Portfolio Pulse from Benzinga Insights
October 15, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Insights
October 14, 2024 | 4:30 pm
Portfolio Pulse from Upwallstreet
October 10, 2024 | 6:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 08, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Insights
October 07, 2024 | 8:31 pm
Portfolio Pulse from Upwallstreet
October 01, 2024 | 6:11 pm
Portfolio Pulse from Benzinga Newsdesk
October 01, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Insights
September 27, 2024 | 4:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.